Columbia Center for Human Development, Columbia University Medical Center, New York, NY, USA.
Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Nat Protoc. 2021 Apr;16(4):1802-1829. doi: 10.1038/s41596-020-00476-z. Epub 2021 Mar 1.
Lung and airway epithelial cells generated in vitro from human pluripotent stem cells (hPSCs) have applications in regenerative medicine, modeling of lung disease, drug screening and studies of human lung development. Here, we describe a strategy for directed differentiation of hPSCs into mature lung and airway epithelial cells obtained through maturation of NKX2.1 hPSC-derived lung progenitors in a 3D matrix of collagen I in the absence of glycogen synthase kinase 3 inhibition. This protocol is an extension of our previously published protocol on the directed differentiation of lung and airway epithelium from hPSCs that modifies the technique and offers additional applications. This protocol is conducted in defined media conditions, has a duration of 50-80 d, does not require reporter lines and results in cultures containing mature alveolar type II and I cells as well as airway basal, ciliated, club and neuroendocrine cells. We also present a flow cytometry strategy to assess maturation in the cultures. Several of these populations, including mature NGFR basal cells, can be prospectively isolated by cell sorting and expanded for further investigation.
体外由人多能干细胞 (hPSC) 生成的肺和气道上皮细胞在再生医学、肺疾病模型、药物筛选和人类肺发育研究中具有应用价值。在这里,我们描述了一种策略,即在胶原 I 3D 基质中,通过成熟 NKX2.1 hPSC 衍生的肺祖细胞,在没有糖原合酶激酶 3 抑制的情况下,将 hPSC 定向分化为成熟的肺和气道上皮细胞。该方案是我们之前发表的关于 hPSC 定向分化为肺和气道上皮细胞的方案的扩展,该方案修改了技术并提供了更多的应用。该方案在定义的培养基条件下进行,持续时间为 50-80 天,不需要报告基因系,可获得成熟的肺泡 II 型和 I 型细胞以及气道基底细胞、纤毛细胞、杯状细胞和神经内分泌细胞。我们还提出了一种流式细胞术策略来评估培养物中的成熟度。这些细胞群中的一些,包括成熟的 NGFR 基底细胞,可以通过细胞分选进行前瞻性分离并进行进一步研究。